Antares Pharma, Inc. (ATRS)

R&D Expenses

$5.01M

Quarterly · Period ending: · USD

ATRS logo

ATRS R&D Expenses

Latest reported$5.01M
ATRS Quarterly R&D Expenses ($0.00 → $5.01M)
High-resolution chart · PNG

ATRS r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
5,008,000
3,892,000
3,923,000
4,047,000
2,640,000
2,318,000
2,405,000
2,417,000
2,981,000
2,880,000
2,863,000
2,494,000
2,387,000
1,747,000
3,611,000
3,650,000
3,320,000
3,611,911
3,289,445
3,159,363
3,086,281
5,572,337
5,958,550
3,948,020
5,648,029
5,642,464
5,142,387
4,568,732
4,377,981
5,734,712
4,426,730
3,942,948
4,533,626
2,990,415
4,460,028
4,583,577
3,229,351
5,661,130
3,900,475
2,482,785
2,877,162
1,574,448
1,429,210
1,946,331
1,749,336
2,141,177
2,332,712
2,242,788
2,085,825
1,945,497
2,004,921
1,745,309
2,206,759
1,955,746
2,153,267
1,791,214
1,966,272
1,364,910
1,652,129
1,521,657
823,595
1,125,519
832,497
959,394
861,059
437,722
922,178
1,083,465
966,121
1,399,178
879,297
603,990
663,973
1,425,641
666,210
687,340
714,775
1,265,611
843,902
813,692
731,128
1,475,201
685,894
823,828
541,709
357,503
302,823
288,840
273,868
517,779
600,000
500,000
700,000
1,616,856
700,000
600,000
600,000
673,814
600,000
700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.